SOURCE: INVO Bioscience, Inc.

December 14, 2009 17:44 ET

INVO Bioscience, Inc. Announces the Posting of an Investor Update on the INVO Bioscience Website

BEVERLY, MA--(Marketwire - December 14, 2009) - INVO Bioscience, Inc. (OTCBB: IVOB), a medical device company focused on treatment options for patients diagnosed with infertility, announced today that it has posted an investor update reviewing activity in 2009 and business planned for 2010. The update can be accessed at http://invobioscience.com/pdf/InvMem.pdf or in the Investor Relations section on the http://INVOBioscience.com website.

During a recent trip to British Columbia, Canada, the INVO team presented its INVOcell procedure to two groups which have shown interest in further pursuing the technology. The two groups indicate their intention to use this procedure to treat part of their infertile patient population.

About INVO Bioscience

INVO Bioscience (IVOB) is a medical device company, headquartered in Beverly, Massachusetts, focused on creating simplified, lower cost treatment options for patients diagnosed with infertility. The company's lead product, the INVOcell, is a novel medical device used in infertility treatment that enables egg fertilization and early embryo development in the woman's vaginal cavity. The company was founded by Claude Ranoux, MD, a noted expert in the field of reproductive health, infertility and embryology. For more information, please visit www.invo-bioscience.com.

This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategies, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, as well as statements that include words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions are forward-looking statements. All forward-looking statements involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. Factors that may cause actual results to differ materially from those in the forward-looking statements include those set forth in our filings at www.sec.gov. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.

Contact Information

  • Contact:
    Kathleen Karloff
    INVO Bioscience, Inc.
    978-878-9505
    Email Contact